Home > Insider Trading > Filing (0001209191-11-031210)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1349077	Lisa Kelly	C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02139	Svp, Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-05-25	1,960	$55.49	40,212	No	4	S	Direct
Common Stock	Disposition	2011-05-25	2,200	$56.22	38,082	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,520	Indirect	401(k)

Footnotes

Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $55.49 (range $55.05 to $55.92).
Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $56.22 (range $56.04 to $56.57).